Boston's CEO (chief executive officer) fights back with attack on Medinol
This article was originally published in Clinica
Executive Summary
Jim Tobin, CEO of Boston Scientific and the centre of accusations by Israeli stent maker Medinol that he revealed to Medinol a secret plot by Boston's previous management to sideline Medinol by starting its own stent manufacturing, has hit back with a stinging attack on Medinol.